Glutamine ABC transporter, glutamine - binding permease inhibitors are compounds that target and inhibit the activity of the ATP-binding cassette (ABC) transporters involved in glutamine uptake. These ABC transporters play a crucial role in transporting glutamine across cellular membranes, particularly through the mechanism of binding permease proteins, which facilitate the movement of glutamine into cells. The permease proteins work as part of a larger multi-subunit complex of the ABC transporter family, where they specifically bind to glutamine and assist in its translocation by coupling with ATP hydrolysis. Inhibition of this system disrupts the normal cellular function of glutamine transport, which is fundamental for various metabolic processes, including nitrogen balance, protein synthesis, and energy metabolism.
The inhibitors targeting this system work by blocking the binding and subsequent transport of glutamine, thereby affecting its intracellular availability. These compounds can interact directly with the permease or potentially with the associated ATP-binding subunits, preventing the conformational changes required for glutamine translocation. As glutamine is a key amino acid that serves as a precursor for various biosynthetic pathways and contributes to cellular growth and maintenance, the inhibition of its transport impacts cellular metabolism. The precise mechanism of action of these inhibitors may vary, including competitive or non-competitive binding to the transporter. Understanding the structure-activity relationship of these inhibitors helps in elucidating their binding specificity and efficacy in blocking glutamine transport. These insights are valuable in research focused on the molecular mechanisms of amino acid transport and metabolism within cells, providing a deeper understanding of the critical role of ABC transporters in nutrient uptake.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Verapamil inhibits the function of ABC transporter permease by blocking its ability to hydrolyze ATP, which is essential for its function as a transporter. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Cyclosporin A binds to the transmembrane domains of ABC transporter permease, inhibiting its substrate binding and transport activity. | ||||||
Elacridar | 143664-11-3 | sc-207613A sc-207613 sc-207613B sc-207613C sc-207613D | 5 mg 10 mg 50 mg 100 mg 1 g | $96.00 $111.00 $403.00 $515.00 $2555.00 | 19 | |
Elacridar competitively inhibits ABC transporter permease by binding to its substrate recognition sites, preventing substrate transport. | ||||||
Ko 143 | 461054-93-3 | sc-204030 sc-204030A | 1 mg 10 mg | $107.00 $256.00 | 21 | |
Ko 143 is a potent inhibitor of ABC transporter permease, preventing the ATP-dependent efflux of substrates across the cellular membrane. | ||||||
PSC 833 | 121584-18-7 | sc-361298 sc-361298A sc-361298B sc-361298C sc-361298D | 1 mg 10 mg 50 mg 100 mg 1 g | $213.00 $724.00 $2522.00 $4253.00 $26884.00 | 12 | |
PSC833 inhibits ABC transporter permease by binding to the ATP-binding cassette, blocking ATP hydrolysis and subsequent substrate transport. | ||||||
MK-571 | 115103-85-0 | sc-201340 sc-201340A | 5 mg 25 mg | $107.00 $413.00 | 8 | |
MK-571 selectively inhibits ABC transporter permease by interfering with the conformational change necessary for substrate translocation across the membrane. | ||||||